Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin - PubMed (original) (raw)
. 2003 Dec 15;63(24):8791-812.
Affiliations
- PMID: 14695196
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin
John M Mariadason et al. Cancer Res. 2003.
Abstract
5-Fluorouracil (5-FU) is the most common chemotherapeutic agent used in the treatment of colorectal cancer, yet objective response rates are low. Recently, camptothecin (CPT) has emerged as an effective alternative therapy. Decisive means to determine treatment, based on the likelihood of response to each of these agents, could greatly enhance the management of this disease. Here, the ability of cDNA microarray-generated basal gene expression profiles to predict apoptotic response to 5-FU and CPT was determined in a panel of 30 colon carcinoma cell lines. Genes whose basal level of expression correlated significantly with 5-FU- and CPT-induced apoptosis were selected, and their predictive power was assessed using a "leave one out" jackknife cross-validation strategy. Selection of the 50 genes best correlated with 5-FU-induced apoptosis, but not 50 randomly selected genes, significantly predicted response to this agent. Importantly, this gene expression profiling approach predicted response more effectively than four previously established determinants of 5-FU response: thymidylate synthase and thymidine phosphorylase activity; and p53 and mismatch repair status. Furthermore, reanalysis of the database demonstrated that selection of the 149 genes best correlated with CPT-induced apoptosis maximally and significantly predicted response to this agent. These studies demonstrate that the basal gene expression profile of colon cancer cells can be used to predict and distinguish response to multiple chemotherapeutic agents and establish the potential of this methodology as a means by which rational decisions regarding choice of therapy can be approached.
Similar articles
- Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
Xi Y, Nakajima G, Schmitz JC, Chu E, Ju J. Xi Y, et al. BMC Genomics. 2006 Apr 3;7:68. doi: 10.1186/1471-2164-7-68. BMC Genomics. 2006. PMID: 16584549 Free PMC article. - Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM, Kravik KL, Tunheim SH, Haug T, Reichelt WH. De Angelis PM, et al. Mol Cancer. 2004 Apr 26;3:11. doi: 10.1186/1476-4598-3-11. Mol Cancer. 2004. PMID: 15109396 Free PMC article. - Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM, Svendsrud DH, Kravik KL, Stokke T. De Angelis PM, et al. Mol Cancer. 2006 May 18;5:20. doi: 10.1186/1476-4598-5-20. Mol Cancer. 2006. PMID: 16709241 Free PMC article. - Determinants of prognosis and response to therapy in colorectal cancer.
Iqbal S, Lenz HJ. Iqbal S, et al. Curr Oncol Rep. 2001 Mar;3(2):102-8. doi: 10.1007/s11912-001-0008-5. Curr Oncol Rep. 2001. PMID: 11177741 Review. - 5-fluorouracil: mechanisms of action and clinical strategies.
Longley DB, Harkin DP, Johnston PG. Longley DB, et al. Nat Rev Cancer. 2003 May;3(5):330-8. doi: 10.1038/nrc1074. Nat Rev Cancer. 2003. PMID: 12724731 Review.
Cited by
- Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.
Yan L, Shi J, Zhu J. Yan L, et al. Discov Oncol. 2024 Jul 20;15(1):294. doi: 10.1007/s12672-024-01163-1. Discov Oncol. 2024. PMID: 39031216 Free PMC article. Review. - A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle.
Li Y, Zhao D, Zhang W, Yang M, Wu Z, Shi W, Lan S, Guo Z, Yu H, Wu D. Li Y, et al. J Transl Med. 2023 Jun 29;21(1):422. doi: 10.1186/s12967-023-04196-2. J Transl Med. 2023. PMID: 37386467 Free PMC article. - Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in Colorectal Cancer.
Tian X, He Y, Qi L, Liu D, Zhou D, Liu Y, Gong W, Han Z, Xia Y, Li H, Wang J, Zhu K, Chen L, Guo H, Zhao Q. Tian X, et al. Int J Biol Sci. 2023 May 29;19(9):2817-2834. doi: 10.7150/ijbs.79949. eCollection 2023. Int J Biol Sci. 2023. PMID: 37324947 Free PMC article. - Screening prognostic genes related to leucovorin, fluorouracil, and irinotecan treatment sensitivity by performing co-expression network analysis for colon cancer.
Wu P, Pan X, Lu K, Gu N. Wu P, et al. Front Genet. 2022 Nov 29;13:928356. doi: 10.3389/fgene.2022.928356. eCollection 2022. Front Genet. 2022. PMID: 36523769 Free PMC article. - Acetate Promotes a Differential Energy Metabolic Response in Human HCT 116 and COLO 205 Colon Cancer Cells Impacting Cancer Cell Growth and Invasiveness.
Rodríguez-Enríquez S, Robledo-Cadena DX, Gallardo-Pérez JC, Pacheco-Velázquez SC, Vázquez C, Saavedra E, Vargas-Navarro JL, Blanco-Carpintero BA, Marín-Hernández Á, Jasso-Chávez R, Encalada R, Ruiz-Godoy L, Aguilar-Ponce JL, Moreno-Sánchez R. Rodríguez-Enríquez S, et al. Front Oncol. 2021 Aug 3;11:697408. doi: 10.3389/fonc.2021.697408. eCollection 2021. Front Oncol. 2021. PMID: 34414111 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous